摘要
目的分析2011—2022年全球恶性疟原虫青蒿素抗药性相关研究文献产出和被引频次,为我国研究人员开展该领域研究工作提供参考。方法在Web of Science核心合集Science Citation Index Expanded(SCIE)数据库中,检索2011年1月—2022年5月有关恶性疟原虫青蒿素抗药性相关文献,对文献学科、期刊、国家(地区)、机构分布以及核心作者、被引频次等进行文献计量学分析。结果2011年1月—2022年5月,在SCIE数据库中共检索到有关恶性疟原虫青蒿素抗药性文献1640篇,发文量总体呈逐年增长趋势。上述文献来自343种期刊,其中发文量居前3位的期刊分别为《Malaria Journal》(341篇,占20.79%)、《Antimicrobial Agents and Chemotherapy》(141篇,占8.60%)和《The American Journal of Tropical Medicine and Hygiene》(68篇,占4.15%),学科分布以感染性疾病(565篇,占34.45%)、寄生虫学(531篇,占32.38%)、热带医学(517篇,占31.54%)为主。发文量居前3位的国家分别为美国(627篇,占38.23%)、英国(395篇,占24.08%)和泰国(294篇,占17.94%),总被引频次分别为25280、18622次和15474次;发文量居前3位的机构分别为泰国玛希隆大学、英国牛津大学和伦敦大学,发文量分别为234、220、142篇,总被引频次分别为15058、15421次和6191次。发文量居前3位的作者均来自泰国玛希隆大学,分别发文85、77篇和63篇。文献总被引频次居前3位的作者中,有2名来自泰国玛希隆大学,总被引频次分别为8623次和7961次;1名来自美国国立卫生研究院,总被引频次为6267次。中国科研人员共发文138篇,总被引频次为3434次;其中中国疾病预防控制中心寄生虫病预防控制所发文量最多,该机构共发表论文35篇,总被引频次为1165次,篇均被引频次为33.29次。结论2011—2022年欧美及部分东南亚国家在恶性疟原虫青蒿素抗药性相关研究领域文献产出较多,学术影响力相对较大。我国研究人员可重点关注《Malaria Journal》、《Antimicrobial Agents and Chemotherapy》等期刊上发表的相关文献,及时掌握该领域的最新进展,拓展研究广度与深度。
Objective To analyze the global literature output and citation of publications pertaining to artemisinin(ART)resistance in Plasmodium falciparum from 2011 to 2021,so as to provide insights into researches on resistance of P.falciparum to ART.Methods The publications pertaining to ART resistance in P.falciparum were retrieved from the Science Citation Index Expanded(SCIE)database in Web of Science during the period from January 2011 through May 2022.The subject,journal,country,affiliation and author distributions and citations of publications were descriptively analyzed.Results A total of 1640 publications pertaining to ART resistance in P.falciparum were retrieved in the SCIE database during the period from January 2011through May 2022,and the number of publications appeared an overall tendency towards a rise during the study period.These articles were published in 343 journals,and the three most productive journals included Malaria Journal(341 publications,20.79%),Antimicrobial Agents and Chemotherapy(141 publications,8.60%),American Journal of Tropical Medicine and Hygiene(68 publications,4.15%),with infectious diseases(565 publications,34.45%),parasitology(531 publications,32.38%),and tropical medicine(517 publications,31.54%)as the predominant subject.The three most productive countries included the United States of America(627 publications,38.23%),United Kingdom(395 publications,24.08%),and Thailand(294 publications,17.94%),with total citations of 25280,18622 and 15474,respectively,and the most productive countries included Mahidol University(Thailand),Oxford University(England)and London University(England),with 234,220 publications and 142 publications and 15058,15421 citations and 6191 citations,respectively.The three most productive authors were all from Mahidol University,with 85,77 and 63 publications,respectively;and among the three most cited authors,two were from Mahidol University,Thailand,with 8623 and 7961 total citations,and one from National Institutes of Health,the United States of America,with6267 total citations.A total of 138 articles were published by Chinese scientists,with 3434 total citations,and National Institute of Parasitic Diseases of Chinese Center for the Diseases Control and Prevention was the most productive Chinese institution,with 35 publications,1165 total citations and 33.29 citations per publication.Conclusions The literature output of ART resistance in P.falciparum was relatively high in the United States of America,Europe,and Southeast Asian countries during the period from 2011 to 2021,with a relatively high academic impact.Publications in Malaria Journal and Antimicrobial Agents and Chemotherapy are recommended to be paid much attention by Chinese scientists to understand the latest advances and extend the research interests.
作者
董丽
李健
王利磊
莫金余
DONG Li;LI Jian;WANG Li-lei;MO Jin-yu(Hubei University of Medicine,Shiyan,Hubei 442000,China;Shandong First Medical University,Shangdong Institute of Parasitic Diseases,Jining,Shandong 272033,China)
出处
《中国血吸虫病防治杂志》
CAS
CSCD
北大核心
2022年第6期639-645,共7页
Chinese Journal of Schistosomiasis Control
基金
国家自然科学基金青年项目(81802046)
湖北医药学院PI项目(HBMUPI202101)
湖北医药学院“十四五”省级优势特色学科群(公共卫生与健康)2022年资助项目(2022PHXKQ1)。